PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1280560
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1280560
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia's war on Ukraine will play out this year and the war's role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Annual Doses of COVID-19 Vaccines estimated at US$255 Million in the year 2020, is projected to reach US$60.7 Billion by 2025. Value of annual doses in China is forecast to stabilize to US$23 billion by 2025, after peaking at US$73 billion in the year 2021. Global percentage of individuals vaccinated by the year 2025 is expected to taper down to 47% by the year 2025 as compared to the 73% estimated for the year 2022.
Vaccinated population in Africa will reach only 12% by the year 2023, a figure that will dwindle to 4% by 2025. In comparison, the percentage of individuals vaccinated in France is expected to touch 92% by the end of 2022. Number of doses administered worldwide is expected to rise to 4,186 million by 2025.
|
|